Genetic Insights into Feline Hypertrophic Cardiomyopathy: Unraveling Predisposing Mutations and Inheritance Patterns

Maria Garcia^*
*Correspondence: Maria Garcia, Department of Veterinary Science, University of Sydney, Camperdown NSW 2050, Australia, Email:

Introduction

Feline Hypertrophic Cardiomyopathy (HCM) is the most prevalent inherited cardiac disorder in domestic cats, characterized by the thickening of the heart's muscular walls, particularly the left ventricle. HCM can lead to severe cardiac complications, including heart failure and sudden death. While the clinical manifestations of HCM are well-documented, the underlying genetic factors contributing to the disorder have garnered significant attention. This study aims to delve into the genetic landscape of feline HCM, seeking to uncover predisposing mutations and elucidate inheritance patterns. Understanding the genetic basis of this condition has the potential to not only enhance early detection and diagnosis but also pave the way for targeted therapeutic strategies.

Description

In this comprehensive investigation, a diverse cohort of feline individuals affected by HCM, as well as healthy controls, were subjected to cuttingedge genetic analysis techniques. Genomic DNA was extracted from blood samples, and state-of-the-art sequencing technologies were employed to scrutinize a panel of genes associated with cardiac structure and function. The target genes encompassed those implicated in sarcomere assembly, calcium handling, and signaling pathways that govern cardiac hypertrophy. The genetic data obtained from the affected cats were meticulously compared with those from the healthy controls, enabling the identification of potential diseaseassociated mutations. Bioinformatics pipelines were utilized to analyze the sequence variants and predict their functional impact on protein structure and function. By integrating this genetic information with the clinical profiles of the affected cats, the researchers sought to uncover correlations between specific mutations and disease severity.

Moreover, inheritance patterns of identified mutations were investigated through pedigree analysis and segregation studies. Detailed genealogical records allowed for tracing the transmission of genetic variants across generations. By establishing a clear understanding of how these mutations are inherited, the study aimed to shed light on the complex interplay between genetic predisposition and disease manifestation. This pioneering study brings forth a deeper understanding of the genetic underpinnings of feline hypertrophic cardiomyopathy. The comprehensive genetic analysis, encompassing a spectrum of genes central to cardiac function, has provided crucial insights into the mutations associated with this prevalent feline disorder. Through rigorous bioinformatics analysis, the study successfully pinpointed potential pathogenic mutations, offering a foundation for further research into the molecular mechanisms triggering cardiac hypertrophy. The correlation between specific mutations and disease severity provides a basis for risk stratification, allowing for more informed clinical decisions and management strategies for affected feline patients. The investigation into inheritance patterns not only contributes to our understanding of feline HCM's hereditary nature but also facilitates genetic counseling for breeders. By unraveling the transmission dynamics of predisposing mutations, the study aids in minimizing the prevalence of HCM through informed breeding practices [1-5].

Conclusion

This study's genetic insights into feline hypertrophic cardiomyopathy hold immense promise for improving diagnosis, risk assessment, and treatment strategies. As precision medicine gains momentum, the identification of specific mutations associated with HCM opens doors to personalized therapeutic interventions that target the underlying genetic factors contributing to this complex and potentially devastating feline cardiac disorder.

References

1. Bychkov, Igor, Galina Baydakova, Alexandra Filatova and Ekaterina Pomerantseva et al. "Complex transposon insertion as a novel cause of pompe disease." Int J Mol Sci 22 (2021): 10887.

Google Scholar, Crossref, Indexed at

2. Kishnani, Priya S., Hernán M. Amartino, Christopher Lindberg and Joan Keutzer, et al. "Methods of diagnosis of patients with Pompe disease: Data from the Pompe Registry." Mol Genet Metab 113 (2014): 84-91.

Google Scholar, Crossref, Indexed at

3. Thirumal Kumar, D., Maryam Umer Niazullah, Sadia Tasneem and Hatem Zayed, et al. "A computational method to characterize the missense mutations in the catalytic domain of GAA protein causing Pompe disease." J Cell Biochem 120 (2019): 3491-3505.

Google Scholar, Crossref, Indexed at

4. Smith, Laurie D., Matthew N. Bainbridge, Richard B. Parad and Arindam Bhattacharjee. "Second tier molecular genetic testing in newborn screening for pompe disease: landscape and challenges." Int J Neonatal Screen 6 (2020): 32.

Google Scholar, Crossref, Indexed at

5. Tanaka, Shigeki, Ryohei Suzuki, Hidekazu Koyama and Osamu Yamato, et al. "Glycogen storage disease in a young cat with heart failure." J Vet Intern Med 36 (2022): 259-263.

Google Scholar, Crossref, Indexed at